Peter E. Light

7.8k citations

116 papers · 5.7k indexed · 1 hit paper · h-index 43

Impact in

Endocrinology, Diabetes and Metabolism top 0.5%
- Diabetes Treatment and Management
Cardiology and Cardiovascular Medicine top 1%
- Cardiac electrophysiology and arrhythmias
- Cardiovascular Function and Risk Factors

Papers in ⓘ

Pathology and Forensic Medicine 43
- Cardiac Ischemia and Reperfusion 40
Cardiology and Cardiovascular Medicine 41
- Cardiac electrophysiology and arrhythmias 27
- Heart Failure Treatment and Management 8

Co-authors: Jason R.B. Dyck (20 shared papers)Michael Riedel (9 shared papers)Michael B. Wheeler (3 shared papers)Robert J. French (7 shared papers)Patrick E. MacDonald (9 shared papers)Jocelyn E. Manning Fox (9 shared papers)István Baczkó (12 shared papers)Michael P. Walsh (5 shared papers)
Journals: Diabetes (10 papers)The Journal of Physiology (7 papers)British Journal of Pharmacology (6 papers)The FASEB Journal (6 papers)Journal of Molecular and Cellular Cardiology (5 papers)
Partner nations: Canada United States United Kingdom

In The Last Decade

Peter E. Light

115 papers receiving 5.6k citations

Hit Papers

align trajectories log scale

Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin 2021 · 144 citations

Peers

Countries citing papers authored by Peter E. Light

Since Specialization

Citations

This map shows the geographic impact of Peter E. Light's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Light with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Light more than expected).

Fields of papers citing papers by Peter E. Light

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter E. Light. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Light. The network helps show where Peter E. Light may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter E. Light, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter E. Light Line = papers co-authored together Peter E. Light links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The Multiple Actions of GLP-1 on the Process of Glucose-Stimulated Insulin Secretion Diabetes ·Patrick E. MacDonald, Wasim El-kholy, Michael Riedel, Anne Marie Salapatek, Peter E. Light, Michael B. Wheeler	2002	461
2	Phosphodiesterase Type 5 Is Highly Expressed in the Hypertrophied Human Right Ventricle, and Acute Inhibition of Phosphodiesterase Type 5 Improves Contractility Circulation ·Jayan Nagendran, Stephen L. Archer, Daniel Soliman, Vikram Gurtu, Rohit Moudgil, Alois Haromy, Chantal St. Aubin, Linda Webster, Ivan M. Rebeyka, David B. Ross, Peter E. Light, Jason R.B. Dyck, Evangelos D. Michelakis	2007	394
3	Upper intestinal lipids trigger a gut–brain–liver axis to regulate glucose production Nature ·Penny Y.T. Wang, Liora Caspi, Carol Lam, Madhu Chari, Xiaosong Li, Peter E. Light, Roger Gutiérrez‐Juárez, Michelle Ang, Gary J. Schwartz, Tony K.T. Lam	2008	238
4	Resveratrol Inhibits Cardiac Hypertrophy via AMP-activated Protein Kinase and Akt Journal of Biological Chemistry ·Anita Y.M. Chan, Vernon W. Dolinsky, Carrie-Lynn M. Soltys, Benoı̂t Viollet, Shairaz Baksh, Peter E. Light, Jason R.B. Dyck	2008	207
5	Resveratrol Prevents the Prohypertrophic Effects of Oxidative Stress on LKB1 Circulation ·Vernon W. Dolinsky, Anita Y.M. Chan, Isabelle Robillard Frayne, Peter E. Light, Christine Des Rosiers, Jason R.B. Dyck	2009	190
6	Empagliflozin Blunts Worsening Cardiac Dysfunction Associated With Reduced NLRP3 (Nucleotide-Binding Domain-Like Receptor Protein 3) Inflammasome Activation in Heart Failure Circulation Heart Failure ·Nikole J. Byrne, Nobutoshi Matsumura, Zaid H. Maayah, Mourad Ferdaoussi, Shingo Takahara, Ahmed M. Darwesh, Jody Levasseur, James W.S. Jahng, Dyonne Vos, Nirmal Parajuli, Ayman O.S. El‐Kadi, Branko Braam, Martin E. Young, Subodh Verma, Peter E. Light, Gary Sweeney, John M. Seubert, Jason R.B. Dyck	2020	177
7	Noninvasive Glucose Sensing in Aqueous Solutions Using an Active Split-Ring Resonator IEEE Sensors Journal ·Mohammad Abdolrazzaghi, Nir Katchinskiy, A. Y. Elezzabi, Peter E. Light, Mojgan Daneshmand	2021	149
8	Non-invasive continuous-time glucose monitoring system using a chipless printable sensor based on split ring microwave resonators Scientific Reports ·Masoud Baghelani, Zahra Abbasi, Mojgan Daneshmand, Peter E. Light	2020	146
9	Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin Circulation ·Koenraad Philippaert, Subha Kalyaanamoorthy, Mohammad Fatehi, Wentong Long, Shubham Soni, Nikole J. Byrne, Amy Barr, Jyoti Singh, Jordan Wong, Taylor Palechuk, Chloe Schneider, Ahmed M. Darwesh, Zaid H. Maayah, John M. Seubert, Khaled Barakat, Jason R.B. Dyck, Peter E. Light Hit paper breakdown →	2021	144
10	Glucagon-Like Peptide-1 Inhibits Pancreatic ATP-Sensitive Potassium Channels via a Protein Kinase A- and ADP-Dependent Mechanism Molecular Endocrinology ·Peter E. Light, Jocelyn E. Manning Fox, Michael Riedel, Michael B. Wheeler	2002	142
11	Protein Kinase C–Induced Changes in the Stoichiometry of ATP Binding Activate Cardiac ATP-Sensitive K⁺Channels Circulation Research ·Peter E. Light, Aftab A. Sabir, Bruce G. Allen, Michael P. Walsh, Robert J. French	1996	135
12	Molecular basis of protein kinase C-induced activation of ATP-sensitive potassium channels Proceedings of the National Academy of Sciences ·Peter E. Light, Chris Bladen, Robert J. Winkfein, Michael P. Walsh, Robert J. French	2000	118
13	Cardiac mechanisms of the beneficial effects of SGLT2 inhibitors in heart failure: Evidence for potential off-target effects Journal of Molecular and Cellular Cardiology ·Jason R.B. Dyck, Samuel Sossalla, Nazha Hamdani, Ruben Coronel, Nina C. Weber, Peter E. Light, Coert J. Zuurbier	2022	100
14	Myocardial ATGL Overexpression Decreases the Reliance on Fatty Acid Oxidation and Protects against Pressure Overload-Induced Cardiac Dysfunction Molecular and Cellular Biology ·Petra C. Kienesberger, Thomas Pulinilkunnil, Miranda M. Sung, Jeevan Nagendran, Guenter Haemmerle, Erin E. Kershaw, Martin E. Young, Peter E. Light, Gavin Y. Oudit, Rudolf Zechner, Jason R.B. Dyck	2011	95
15	Islet Cholesterol Accumulation Due to Loss of ABCA1 Leads to Impaired Exocytosis of Insulin Granules Diabetes ·Janine K. Kruit, Nadeeja Wijesekara, Jocelyn E. Manning Fox, Xiao-Qing Dai, Liam R. Brunham, Gavin J. Searle, Garry Morgan, Adam Costin, Renmei Tang, Alpana Bhattacharjee, James D. Johnson, Peter E. Light, Brad J. Marsh, Patrick E. MacDonald, C. Bruce Verchere, Michael R. Hayden	2011	93
16	Coexpression of the Type 2 Diabetes Susceptibility Gene Variants KCNJ11 E23K and ABCC8 S1369A Alter the ATP and Sulfonylurea Sensitivities of the ATP-Sensitive K+ Channel Diabetes ·Kevin S.C. Hamming, Daniel Soliman, Laura C. Matemisz, Omid Niazi, Yiqiao Veronica Lang, Anna L. Gloyn, Peter E. Light	2009	85
17	N-acyl Taurines and Acylcarnitines Cause an Imbalance in Insulin Synthesis and Secretion Provoking β Cell Dysfunction in Type 2 Diabetes Cell Metabolism ·Michaela Aichler, Daniela Borgmann, Jan Krumsiek, Achim Buck, Patrick E. MacDonald, Jocelyn E. Manning Fox, James Lyon, Peter E. Light, Susanne Keipert, Martin Jastroch, Annette Feuchtinger, Nikola S. Mueller, Na Sun, Andrew Palmer, Theodore Alexandrov, Martin Hrabě de Angelis, Susanne Neschen, Matthias H. Tschöp, Axel Walch	2017	83
18	Kir6.2 Polymorphisms Sensitize β-Cell ATP-Sensitive Potassium Channels to Activation by Acyl CoAs Diabetes ·Michael Riedel, Parveen Boora, Diana Steckley, Gerda de Vries, Peter E. Light	2003	79
19	Variations in tissue selectivity amongst insulin secretagogues: a systematic review Diabetes Obesity and Metabolism ·Ahmed S. Abdel‐Moneim, Susan Hasenbank, John M. Seubert, Dion R. Brocks, Peter E. Light, Scot H. Simpson	2011	77
20	Constitutively Active Adenosine Monophosphate–Activated Protein Kinase Regulates Voltage-Gated Sodium Channels in Ventricular Myocytes Circulation ·Peter E. Light, Catriona H.R. Wallace, Jason R.B. Dyck	2003	75

About Peter E. Light

Peter E. Light is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine, Sensory Systems, Endocrinology, Diabetes and Metabolism and Cellular and Molecular Neuroscience, having authored 116 papers that have together received 5.7k indexed citations. Recurring topics across this work include Cardiac Ischemia and Reperfusion (40 papers), Ion channel regulation and function (38 papers), Cardiac electrophysiology and arrhythmias (27 papers), Pancreatic function and diabetes (26 papers), Diabetes Treatment and Management (14 papers), Metabolism, Diabetes, and Cancer (9 papers), Cardiac Arrest and Resuscitation (9 papers) and Heart Failure Treatment and Management (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.4k citations), Cardiology and Cardiovascular Medicine (1.5k citations), Geriatrics and Gerontology (222 citations), Pathology and Forensic Medicine (978 citations) and Endocrine and Autonomic Systems (305 citations). Peter E. Light has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Jason R.B. Dyck, Michael Riedel, Michael B. Wheeler, Robert J. French, Patrick E. MacDonald, Jocelyn E. Manning Fox, István Baczkó, Michael P. Walsh, Anne Marie Salapatek and Vernon W. Dolinsky. Their work appears in journals such as Diabetes, The Journal of Physiology, British Journal of Pharmacology, The FASEB Journal and Journal of Molecular and Cellular Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact